C4 Therapeutics to Present Cemsidomide Biomarker Data in Multiple Myeloma
Watertown, Mass., September 3, 2026 C4 Therapeutics announced that new biomarker data evaluating the immunomodulatory effects of cemsidomide in...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Watertown, Mass., September 3, 2026 C4 Therapeutics announced that new biomarker data evaluating the immunomodulatory effects of cemsidomide in...
New York, September 2, 2026 SELLAS Life Sciences Group, Inc. announced that three abstracts evaluating SLS009 (tambiciclib), a potent...
NATICK, MASSACHUSETTS, AND RENO, NEVADA, Aug 27, 2026 Pillar Biosciences, Inc. and Hamilton Company have announced the validation and...
Austin, Texas – August 27, 2026 Natera and Angiex have entered a new collaboration to assess treatment response to...
Los Angeles, California, USA, August 21, 2026 Allies of Skin has announced the launch of Peptint Tripeptide & Goji...
North Chicago, Illinois, USA, August 21, 2026 AbbVie has announced new clinical, translational and real-world research findings that will...
MAINZ, Germany, August 20, 2026 BioNTech SE is set to highlight major progress across its lung cancer clinical development...
South San Francisco, California, August 19, 2026 IDEAYA Biosciences has entered into a clinical collaboration with Genentech, a member...
BALLERUP, DENMARK, August 18, 2026 LEO Pharma has entered into an agreement to acquire worldwide rights to dersimelagon from...
LONDON, August 18, 2026 Smith+Nephew and Imperial College London have launched a new five-year partnership to accelerate innovation in...
